Analysts Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Price Target at $27.27

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have been assigned a consensus recommendation of “Hold” from the twelve analysts that are currently covering the company, Marketbeat.com reports. Eight research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $27.27.

XRAY has been the topic of several research reports. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a report on Friday, November 8th. Mizuho started coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 target price on the stock. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Barrington Research decreased their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, November 8th. Finally, UBS Group cut their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a report on Tuesday, December 3rd.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds have recently bought and sold shares of XRAY. UMB Bank n.a. boosted its holdings in shares of DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after buying an additional 753 shares during the period. Capital Performance Advisors LLP acquired a new stake in shares of DENTSPLY SIRONA in the third quarter valued at about $27,000. Kennebec Savings Bank bought a new position in shares of DENTSPLY SIRONA in the third quarter worth about $35,000. Van ECK Associates Corp bought a new stake in DENTSPLY SIRONA during the 3rd quarter valued at approximately $42,000. Finally, Allworth Financial LP increased its position in DENTSPLY SIRONA by 40.2% in the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock worth $59,000 after buying an additional 625 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $18.12 on Friday. The stock’s 50 day moving average price is $19.16 and its 200 day moving average price is $23.08. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The stock has a market cap of $3.60 billion, a price-to-earnings ratio of -8.75, a PEG ratio of 1.93 and a beta of 0.96. DENTSPLY SIRONA has a 12 month low of $17.21 and a 12 month high of $37.35.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping the consensus estimate of $0.48 by $0.02. The firm had revenue of $951.00 million for the quarter, compared to analysts’ expectations of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. DENTSPLY SIRONA’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.49 earnings per share. Equities research analysts anticipate that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 3.53%. The ex-dividend date of this dividend was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -30.92%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.